MicroRNA-125b promotes tumor metastasis through targeting tumor protein 53-induced nuclear protein 1 in patients with non-small-cell lung cancer

作者: Qinchuan Li , Yang Han , Chunhong Wang , Shan Shan , Yuanyuan Wang

DOI: 10.1186/S12935-015-0233-X

关键词:

摘要: Lung cancer, predominantly non-small-cell lung cancer (NSCLC), is the leading cause of deaths worldwide. There a great need to identify critical effectors involved in metastasis NSCLC that will facilitate development new therapeutic strategies. Here we evaluated potential role miR-125b cells. Human cells were isolated from surgical tissues with Cancer Cell Isolation Kit. Expressions and TP53INP1 detected real-time PCR western blot. mimics, inhibitor, expression plasmid siRNA transfected into nucleofector transfection kit. was determined adhesion assay, invasive assay tumor model. The significantly higher poorly differentiated are endowed high metastatic potentials. Up-regulation could enhance vitro vivo, while down-regulation resulted decreased potentials vivo. Further, protein 53-induced nuclear 1 (TP53INP1) an important target served as negative regulator metastasis. Decreased inversely associated their miR-125b, lower tumors correlated clinical stages patients NSCLC. These findings demonstrated promoted via targeting human cells, which uncovered real relevance microRNAs biology, provided novel candidates for practice.

参考文章(36)
Pei-Hong Jiang, Yoshiharu Motoo, Stéphane Garcia, Juan Lucio Iovanna, Marie-Josèphe Pébusque, Norio Sawabu, Down-expression of tumor protein p53-induced nuclear protein 1 in human gastric cancer World Journal of Gastroenterology. ,vol. 12, pp. 691- 696 ,(2006) , 10.3748/WJG.V12.I5.691
Harvey F. Lodish, Ng Shyh-Chang, Swea Ling Khaw, Minh T. N. Le, Cathleen Teh, Junliang Tay, Lingzi Chin, Vladimir Korzh, Judy Lieberman, Henry Yang, Bing Lim, Ashish Lal, Conserved Regulation of p53 Network Dosage by MicroRNA–125b Occurs through Evolving miRNA–Target Gene Pairs PLoS. ,(2011)
Rebecca Siegel, Elizabeth Ward, Otis Brawley, Ahmedin Jemal, Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA: A Cancer Journal for Clinicians. ,vol. 61, pp. 212- 236 ,(2011) , 10.3322/CAAC.20121
Lei Shi, Junxia Zhang, Tianhong Pan, Jinfang Zhou, Weiyi Gong, Ning Liu, Zhen Fu, Yongping You, MiR-125b is critical for the suppression of human U251 glioma stem cell proliferation Brain Research. ,vol. 1312, pp. 120- 126 ,(2010) , 10.1016/J.BRAINRES.2009.11.056
Qinchuan Li, Yang Han, Guangru Fei, Zhongliang Guo, Tao Ren, Zhongmin Liu, IL-17 promoted metastasis of non-small-cell lung cancer cells Immunology Letters. ,vol. 148, pp. 144- 150 ,(2012) , 10.1016/J.IMLET.2012.10.011
Shu Okamura, Hirofumi Arakawa, Tomoaki Tanaka, Hiroshi Nakanishi, Ching Ching Ng, Yoichi Taya, Morito Monden, Yusuke Nakamura, p53DINP1, a p53-inducible gene, regulates p53-dependent apoptosis. Molecular Cell. ,vol. 8, pp. 85- 94 ,(2001) , 10.1016/S1097-2765(01)00284-2
Ming Zhou, Zixing Liu, Yuhua Zhao, Yan Ding, Hao Liu, Yaguang Xi, Wei Xiong, Guiyuan Li, Jianrong Lu, Oystein Fodstad, Adam I. Riker, Ming Tan, MicroRNA-125b Confers the Resistance of Breast Cancer Cells to Paclitaxel through Suppression of Pro-apoptotic Bcl-2 Antagonist Killer 1 (Bak1) Expression Journal of Biological Chemistry. ,vol. 285, pp. 21496- 21507 ,(2010) , 10.1074/JBC.M109.083337
Xi Chen, Jin Wan, Jiankun Liu, Wei Xie, Xinwei Diao, Jianping Xu, Bo Zhu, Zhengtang Chen, Increased IL-17-producing cells correlate with poor survival and lymphangiogenesis in NSCLC patients Lung Cancer. ,vol. 69, pp. 348- 354 ,(2010) , 10.1016/J.LUNGCAN.2009.11.013
Qinchuan Li, Xiaoman Li, Zhongliang Guo, Feng Xu, Jingyan Xia, Zhongmin Liu, Tao Ren, MicroRNA-574-5p Was Pivotal for TLR9 Signaling Enhanced Tumor Progression via Down-Regulating Checkpoint Suppressor 1 in Human Lung Cancer PLOS ONE. ,vol. 7, ,(2012) , 10.1371/JOURNAL.PONE.0048278
En-hai Cui, Hong-jiao Li, Feng Hua, Bin Wang, Wei Mao, Xue-ren Feng, Jian-you Li, Xiang Wang, Serum microRNA 125b as a diagnostic or prognostic biomarker for advanced NSCLC patients receiving cisplatin-based chemotherapy Acta Pharmacologica Sinica. ,vol. 34, pp. 309- 313 ,(2013) , 10.1038/APS.2012.125